Table 1 Antibody immunoreactivities
Antibody | Source | mAb/pAb | Dilution | Axs | Cgl | MN | HI |
|---|---|---|---|---|---|---|---|
Cy/Pia | Makita et al. (30) | mAb | 1:24,000 | + 3 | +4 | + 1 | − |
Arg-Lys Imia | Al-Abed and Bucala (31) | pAb | 1:900 | + 3 | +3 | + 1 | − |
Pentosidine | Smith et al. (35) | pAb | 1:500 | +2 | +2 | + 1 | − |
Pyrraline | Smith et al. (35) | mAb | 1:300 | + 3 | + 2 | + 1 | − |
SOD1 | Sigma | mAb | 1:500 | + 3 | + 3 | + 1 | + 1 |
Ubiquitin | DAKO | pAb | 1:50 | +2 | + 1 | − | +4 |
NF-p | SMI | mAb | 1:100 | +4 | +4 | − | − |
NF-np | SMI | mAb | 1:100 | + 3 | +4 | +2 | + 1 |
NF-L-np | Zymed | mAb | 1:50 | + 3 | +4 | + 1 | − |
b-NOS | Affinity | pAb | 1:200 | + 1 | +2 | − | + 1 |
Nitrotyrosine | Beckman et al. (9) | mAb | 1:40 | + 1 | +2 | + 1 | − |